T. N. Yikilmaz, A. Dirim, E. S. Ayva, H. Ozdemir, and H. Ozkardes, “Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin”, Urol J, vol. 13, no. 3, pp. 2677–2683, Jun. 2016.